- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 9, 2025 | 969.83K sh |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $42.39K |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $131.43K |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $41.97K |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $219.95K |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $429.46K |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $595.89K |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $779.69K |
| Current Assets | Q3 2025 · Mar 31, 2025 | $716.69K |
| Current Assets | Q3 2025 · Jun 30, 2024 | $990.56K |
| Total Assets | Q3 2025 · Mar 31, 2025 | $1.41M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $1.58M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 2M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 2M sh |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $292.18K |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $834.86K |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $940.76K |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $896.43K |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.14 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.16 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.14 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.16 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $143.69K |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $508.56K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$105.9K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$61.57K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$140.07K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$58.96K |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $70.94K |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $724.02K |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $343.66K |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $2.14M |